According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.99. In 2022 the company made an earnings per share (EPS) of -$4.15 a decrease over its 2021 EPS that were of -$1.29.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.78 | -57% |
2022 | -$4.15 | 220.55% |
2021 | -$1.29 | -34.23% |
2020 | -$1.97 | -15.27% |
2019 | -$2.32 | -46.09% |
2018 | -$4.31 | 9.95% |
2017 | -$3.92 | -3.49% |
2016 | -$4.06 | -10.19% |
2015 | -$4.52 | 321.85% |
2014 | -$1.07 |